Stephen A. Thomson

2.1k total citations
29 papers, 1.7k citations indexed

About

Stephen A. Thomson is a scholar working on Molecular Biology, Organic Chemistry and Rheumatology. According to data from OpenAlex, Stephen A. Thomson has authored 29 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 10 papers in Organic Chemistry and 4 papers in Rheumatology. Recurrent topics in Stephen A. Thomson's work include DNA and Nucleic Acid Chemistry (8 papers), Carbohydrate Chemistry and Synthesis (7 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Stephen A. Thomson is often cited by papers focused on DNA and Nucleic Acid Chemistry (8 papers), Carbohydrate Chemistry and Synthesis (7 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Stephen A. Thomson collaborates with scholars based in United States and United Kingdom. Stephen A. Thomson's co-authors include Stewart A. Noble, C. Fred Hassman, Lee E. Babiss, John Bisi, Jeffery C. Hanvey, Daniel J. Ricca, Rodolfo Cadilla, John A. Josey, Nancy J. Peffer and Stephen C. Brown and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Stephen A. Thomson

29 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen A. Thomson United States 14 1.3k 316 115 68 63 29 1.7k
Tam L. Nguyen United States 14 409 0.3× 180 0.6× 37 0.3× 158 2.3× 96 1.5× 25 875
Jerome L. Gabriel United States 19 623 0.5× 135 0.4× 43 0.4× 34 0.5× 169 2.7× 54 1.0k
Alicia B Berger United States 8 633 0.5× 264 0.8× 90 0.8× 192 2.8× 23 0.4× 8 914
Philippe Cuniasse France 19 625 0.5× 169 0.5× 45 0.4× 147 2.2× 82 1.3× 31 968
Ann M. Dixon United Kingdom 21 765 0.6× 92 0.3× 68 0.6× 66 1.0× 99 1.6× 52 1.3k
Derek J. Smith Singapore 16 566 0.4× 90 0.3× 112 1.0× 328 4.8× 24 0.4× 26 1.1k
Zofia Gdaniec Poland 22 1.2k 1.0× 165 0.5× 36 0.3× 71 1.0× 37 0.6× 88 1.7k
Arthur F. Kluge United States 22 598 0.5× 804 2.5× 33 0.3× 125 1.8× 101 1.6× 64 1.5k
Tony Ly United Kingdom 27 1.2k 0.9× 124 0.4× 16 0.1× 173 2.5× 70 1.1× 49 1.9k
L. Böhm South Africa 26 1.3k 1.0× 118 0.4× 38 0.3× 289 4.3× 109 1.7× 89 2.0k

Countries citing papers authored by Stephen A. Thomson

Since Specialization
Citations

This map shows the geographic impact of Stephen A. Thomson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen A. Thomson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen A. Thomson more than expected).

Fields of papers citing papers by Stephen A. Thomson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen A. Thomson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen A. Thomson. The network helps show where Stephen A. Thomson may publish in the future.

Co-authorship network of co-authors of Stephen A. Thomson

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen A. Thomson. A scholar is included among the top collaborators of Stephen A. Thomson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen A. Thomson. Stephen A. Thomson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haffner, Curt D., Stephen A. Thomson, Yu Guo, et al.. (2010). N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 inhibitors. Part 1. Bioorganic & Medicinal Chemistry Letters. 20(23). 6983–6988. 11 indexed citations
2.
Haffner, Curt D., Stephen A. Thomson, Yu Guo, et al.. (2010). Substituted N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 ion channel blockers. Part 2. Bioorganic & Medicinal Chemistry Letters. 20(23). 6989–6992. 9 indexed citations
3.
Evans, Karen A., Frank T. Coppo, Todd L. Graybill, et al.. (2008). Amino acid anthranilamide derivatives as a new class of glycogen phosphorylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(14). 4068–4071. 9 indexed citations
4.
Sparks, Steven M., D. Mark Bickett, H. Luke Carter, et al.. (2008). Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroups. Bioorganic & Medicinal Chemistry Letters. 19(3). 976–980. 6 indexed citations
5.
Thomson, Stephen A., D. Mark Bickett, Joyce A. Boucheron, et al.. (2008). Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy. Bioorganic & Medicinal Chemistry Letters. 19(4). 1177–1182. 16 indexed citations
6.
Sparks, Steven M., D. Mark Bickett, Scott H. Dickerson, et al.. (2008). Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residues. Bioorganic & Medicinal Chemistry Letters. 19(3). 981–985. 5 indexed citations
7.
Smalley, Terrence L., Andrew J. Peat, Joyce A. Boucheron, et al.. (2006). Synthesis and evaluation of novel heterocyclic inhibitors of GSK-3. Bioorganic & Medicinal Chemistry Letters. 16(8). 2091–2094. 42 indexed citations
8.
Coppo, Frank T., Karen A. Evans, Todd L. Graybill, et al.. (2006). Synthesis and structure–activity relationships of 3-phenyl-2-propenamides as inhibitors of glycogen phosphorylase a. Bioorganic & Medicinal Chemistry Letters. 16(22). 5892–5896. 6 indexed citations
9.
Peat, Andrew J., Joyce A. Boucheron, Scott H. Dickerson, et al.. (2004). Novel pyrazolopyrimidine derivatives as GSK-3 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(9). 2121–2125. 58 indexed citations
10.
Peat, Andrew J., et al.. (2004). Novel GSK-3 inhibitors with improved cellular activity. Bioorganic & Medicinal Chemistry Letters. 14(9). 2127–2130. 46 indexed citations
11.
Hildyard, John, Carina Ämmälä, Iain Dukes, Stephen A. Thomson, & Andrew P. Halestrap. (2004). Identification and characterisation of a new class of highly specific and potent inhibitors of the mitochondrial pyruvate carrier. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1707(2-3). 221–230. 91 indexed citations
12.
Peat, Andrew J., et al.. (2004). Novel GSK‐3 Inhibitor with Improved Cellular Activity.. ChemInform. 35(35). 5 indexed citations
13.
Tavares, Francis X., Joyce A. Boucheron, Scott H. Dickerson, et al.. (2004). N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as Potent and Selective Inhibitors of Glycogen Synthase Kinase 3 with Good Cellular Efficacy. Journal of Medicinal Chemistry. 47(19). 4716–4730. 75 indexed citations
14.
Dearden, John C., et al.. (2003). QSAR studies on P-glycoprotein-regulated multidrug resistance and on its reversal by phenothiazines*. SAR and QSAR in environmental research. 14(5-6). 447–454. 10 indexed citations
15.
Peat, Andrew J., et al.. (2003). 3-Trifluoromethyl-4-nitro-5-arylpyrazoles are novel KATP channel agonists. Bioorganic & Medicinal Chemistry Letters. 14(3). 813–816. 11 indexed citations
16.
Peat, Andrew J., Claire Townsend, Jennings F. Worley, et al.. (2002). Synthesis and evaluation of 7-substituted-3-cyclobutylamino-4H-1,2,4-benzothiadiazine-1,1-dioxide derivatives as KATP channel agonists. Bioorganic & Medicinal Chemistry Letters. 12(20). 2977–2980. 8 indexed citations
17.
Bonham, Michele A., Stephen Brown, Ann L. Boyd, et al.. (1995). An assessment of the antisense properties of RNase H-competent and steric-blocking oligomers. Nucleic Acids Research. 23(7). 1197–1203. 134 indexed citations
18.
Noble, Stewart A., Michele A. Bonham, John Bisi, et al.. (1995). Impact of biophysical parameters on the biological assessment of peptide nucleic acids, antisense inhibitors of gene expression. Drug Development Research. 34(2). 184–195. 22 indexed citations
19.
Thomson, Stephen A., John A. Josey, Rodolfo Cadilla, et al.. (1995). ChemInform Abstract: Fmoc‐Mediated Synthesis of Peptide Nucleic Acids.. ChemInform. 26(38). 3 indexed citations
20.
Pirrung, Michael C. & Stephen A. Thomson. (1988). Total synthesis of pentalenolactone G methyl ester. The Journal of Organic Chemistry. 53(1). 227–230. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026